CA
AMED

Cetera Advisors’s Amedisys AMED Stock Holding History

Cetera Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.56M Buy
+16,881
New +$1.58M 0.01% 937

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Cetera Advisors's AMED Position: Q1 2024 in Review

Cetera Advisors opened a new position in Amedisys (AMED) in Q1 2024: 16,881 shares worth $1.56M. The stake represents 0.01% of the portfolio and ranks #937 among its holdings.

283 funds tracked by Wall St. Rank hold AMED as of Q1 2024.

  • Cetera Advisors held 16,881 shares of Amedisys worth $1.56M as of Q1 2024.
  • Amedisys was a new Cetera Advisors position in Q1 2024.
  • Amedisys made up 0.01% of Cetera Advisors's portfolio in Q1 2024, its #937 holding.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.